Biotech major Mylan launches insulin biosimilar
Biotechnology major Biocon and pharmaceutical company Mylan N V announced the launch of their insulin biosimilar Semglee, indicated for the treatment of diabetes, in Australia. Continue Reading
Biotechnology major Biocon and pharmaceutical company Mylan N V announced the launch of their insulin biosimilar Semglee, indicated for the treatment of diabetes, in Australia. Continue Reading
Some things are intensely personal. Music is such. Almost everyone loves music but the reasons you love it are your own. It is as if you dip into a community pond to scoop out your special share which you deem distinct. Any way, that’s how I justify my ‘exclusive’ bond with my favourites who all just ‘happen’ to be in public domain! Continue Reading